---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-080564"
form_type: "8-K"
ticker: "DTIL"
cik: "0001357874"
company_name: "PRECISION BIOSCIENCES INC"
filed_at: "2025-06-03T23:59:59+00:00"
generated_at: "2026-05-20T01:11:15.411859+00:00"
event_type: "other"
sentiment: "negative"
materiality_score: 0.5
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Precision BioSciences' charter amendment for officer exculpation fails at annual meeting

## Summary
- Kevin J. Buehler and Shari Lisa Piré elected as Class III directors.
- Deloitte & Touche ratified as auditor (7,445,447 FOR, 12,604 against).
- Advisory say-on-pay approved; board sets frequency at every 1 year.
- Proposal for officer exculpation amendment failed: ~3.5M FOR votes (95% of cast) but not >50% of outstanding shares, largely due to 3.75M broker non-votes.

## SEC filing metadata
- accession: 0000950170-25-080564
- form_type: 8-K
- ticker: DTIL
- cik: 0001357874
- company_name: PRECISION BIOSCIENCES INC
- filed_at: 2025-06-03T23:59:59+00:00
- event_type: other
- sentiment: negative
- materiality_score: 0.5
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1357874/000095017025080564/0000950170-25-080564-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1357874/000095017025080564/dtil-20250528.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-080564
- JSON: https://secwatch.observer/filing/0000950170-25-080564.json
- Plain text: https://secwatch.observer/filing/0000950170-25-080564.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.